- Aust Prescr 2004;27:87-90
- 1 December 2004
- DOI: 10.18773/austprescr.2004.141
Some of the views expressed in the following notes on newly approved products should be regarded as preliminary, as there may have been limited published data at the time of publication, and little experience in Australia of their safety or efficacy. However, the Editorial Executive Committee believes that comments made in good faith at an early stage may still be of value. Before new drugs are prescribed, the Committee believes it is important that more detailed information is obtained from the manufacturer's approved product information, a drug information centre or some other appropriate source.
Gopten (Abbott) 4 mg capsules
* At the time the comment was prepared, information about this drug was available on the web site of the Food and Drug Administration in the USA (www.fda.gov).
† At the time the comment was prepared, a scientific discussion about this drug was available on the web site of the European Agency for the Evaluation of Medicinal Products (www.emea.eu.int).
Australian Medicines Handbook 2005
The paper and CD-ROM version of the Australian Medicines Handbook is now published on an annual cycle. Available in January, the 2005edition is comprehensively updated.
Pre-publication offer: order by 24 December, receive your copy in January. Prices include GST but not postage. Book $128, CD-ROM (eAMH) $128, student price $99